|
Sensiblex
|
40 mg/ml
|
V/DCP/17/0026
|
Veyx-Pharma GmbH, Vācija
|
QG02CX90
|
cattle
|
|
Medicinal product information
| Pharmaceutical form: |
solution for injection
|
| International name (active substance): |
Denaverine hydrochloride
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Veyx-Pharma GmbH, Vācija;Veyx-Pharma B.V., Nīderlande
|
| Date of authorisation/renewal: |
27-Jul-2022
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
DCP
|
| Package leaflet: |
[DOCX] 27072022LI (12-Aug-2025)
|
| Labelling text: |
[DOCX] 27072022M (27-Jul-2022)
|
| Summary of product characteristics: |
[DOCX] 27092022ZA (27-Sep-2022)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/17/0026-01 |
40 mg/ml |
1 |
Stikla flakons, 10 ml |
-
|
| V/DCP/17/0026-02 |
40 mg/ml |
1 |
Stikla flakons, 50 ml |
-
|
|